Prevention and management of complications associated with the hydroxyapatite implant

被引:96
作者
Kaltreider, SA
Newman, SA
机构
[1] University of Virginia, Charlottesville, VA
[2] Box 475, UVA-HSC, Charlottesville
关键词
hydroxyapatite implant; exposure; implant position;
D O I
10.1097/00002341-199603000-00004
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The hydroxyapatite orbital implant offers many advantages compared to conventional implants; however, its use is not entirely free of complications. The objectives of this study are to review the complications encountered with the hydroxyapatite orbital implant, suggest mechanisms contributing to the development of these complications, and emphasize aspects of surgical technique that will minimize the risk of the most frequent complication, implant exposure. Preoperative, operative, and postoperative records of 154 patients receiving primary and secondary hydroxyapatite implants were studied retrospectively. Three clinical types of exposure defects were observed; dehiscences along the horizontal suture line, defects over holes in the hydroxyapatite, and a defect adjacent to the site of radiation plaque therapy. Most small exposures healed spontaneously. Medium and large defects were associated with anteriorly malpositioned implants, most often required surgical intervention, and were successfully managed with one or a combination of techniques including flaps, mucous membrane grafts, or repositioning of the implant more posteriorly. Placing the hydroxyapatite implant as far posteriorly as possible and advancing the extraocular muscles 3-5 mm from the apex of the implant will prevent most exposures. Unlike other types of implants, the hydroxyapatite implant does not migrate or extrude, and when exposed, usually does not require removal.
引用
收藏
页码:18 / 31
页数:14
相关论文
共 12 条
[1]  
Beyer C K, 1970, Trans Am Acad Ophthalmol Otolaryngol, V74, P1311
[2]   TISSUE BREAKDOWN AND EXPOSURE ASSOCIATED WITH ORBITAL HYDROXYAPATITE IMPLANTS [J].
BUETTNER, H ;
BARTLEY, GB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 113 (06) :669-673
[3]  
DUTTON JJ, 1991, OPHTHALMOLOGY, V98, P370
[4]  
GOLDBERG RA, 1992, OPHTHALMOLOGY, V99, P831
[5]  
Mc Cord CD, 1976, T AM ACAD OPHTHALMOL, V81, P587
[6]   EXPOSURE RATE OF HYDROXYAPATITE SPHERES IN THE ANOPHTHALMIC SOCKET - HISTOPATHOLOGIC CORRELATION AND COMPARISON WITH SILICONE SPHERE IMPLANTS [J].
NUNERY, WR ;
HEINZ, GW ;
BONNIN, JM ;
MARTIN, RT ;
CEPELA, MA .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 1993, 9 (02) :96-104
[7]  
PERRY AC, 1990, ADV OPHTHALMIC PLAST, P75
[8]  
PERRY AC, 1989, INTEGRATED ORBITAL I
[9]   HYDROXYAPATITE ORBITAL IMPLANT AFTER ENUCLEATION - EXPERIENCE WITH INITIAL 100 CONSECUTIVE CASES [J].
SHIELDS, CL ;
SHIELDS, JA ;
DEPOTTER, P .
ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (03) :333-338
[10]   PROBLEMS WITH THE HYDROXYAPATITE ORBITAL IMPLANT - EXPERIENCE WITH 250 CONSECUTIVE CASES [J].
SHIELDS, CL ;
SHIELDS, JA ;
DEPOTTER, P ;
SINGH, AD .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1994, 78 (09) :702-706